@misc{Skórski_Tomasz_Antisense_1996,
 author={Skórski, Tomasz and Nieborowska-Skórska, Małgorzata and Szczylik, Cezary and Calabretta, Bruno},
 volume={35},
 number={4},
 copyright={Creative Commons Attribution BY-SA 4.0 license},
 journal={Biotechnologia, vol.35, 4 (1996)-.},
 howpublished={online},
 year={1996},
 publisher={Committee on Biotechnology PAS},
 publisher={Institute of Bioorganic Chemistry PAS},
 language={eng},
 abstract={In recent years, the antisense strategy for cancer therapy has progressed from in vitro culturestudies, to investigations in animal models, and now to clinical studies. We describe here thecurrent state of progress toward gene-directed antisense-based cancer therapy targetingBCR/ABL oncogene, primarily from the viewpoint of initial proof-of-concepts studies in animalmodels of human leukemias and phase I clinical investigations.},
 type={Text},
 title={Antisense Oligodeoxynucleotides: from the Bench to the Patient},
 URL={http://rcin.org.pl/Content/146559/PDF/POZN271_182229_biotechnologia-1996-no4-skorski.pdf},
 keywords={biotechnology},
}